课题基金 / 基金详情

THERAPEUTIC INDIUM 111 PENTETREOTIDE IN SOMATOSTAIN RECEPTOR EXPRESSING CANCERS

THERAPEUTIC INDIUM 111 PENTETREOTIDE IN SOMATOSTAIN RECEPTOR EXPRESSING CANCERS
表达癌症的生长抑素受体中的治疗性铟 111 戊曲肽
批准号:
6309629
负责人:
LOWELL B ANTHONY
金额:
$1.12万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30

项目摘要

项目成果

LOWELL B ANTHONY的其他基金

相似基金

相关文献

中文摘要
翻译
本研究将评估高剂量(180mci)的铟111戊曲肽用于治疗对标准治疗有耐药性或治疗失败的表达生长抑素的肿瘤的安全性和有效性。受试者将接受这种放射性生长抑素类似物,通常用于低剂量的扫描。它将静脉注射,随后进行剂量测定,以评估身体对新药物的反应。血液检查和尿液收集将提供关于体内残留放射性水平的信息。患者还将在核医学部门接受扫描以评估放射性水平。
英文摘要
This study will evaluate the safety and efficacy of Indium 111 pentetreotide in high doses (180mci) for treatment of somatostatin expressing neoplasms which are resistant to or have failed standard therapy. The subjects will receive this radioactive-somatostatin analog, normally used for scanning in low doses. It will be administered intravenously with subsequent dosimetry to assess the body's response to the new agent. Blood work and urine collections will be obtained to provide information about the levels of radioactivity remaining in the body. The patient will also be seen in the nuclear medicine department for scanning to assess radioactive levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protocol Review and Monitoring System
  • 批准号:
    10712125
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2013
  • 负责人:
    LOWELL B ANTHONY
  • 依托单位:
Protocol Review and Monitoring System
  • 批准号:
    10470124
  • 项目类别:
  • 资助金额:
    $7.04万
  • 财政年份:
    2013
  • 负责人:
    LOWELL B ANTHONY
  • 依托单位:
Protocol Review and Monitoring System
  • 批准号:
    10204902
  • 项目类别:
  • 资助金额:
    $7.04万
  • 财政年份:
    2013
  • 负责人:
    LOWELL B ANTHONY
  • 依托单位:
STUDY TO EVALUATE THE EFFECT OF AGE AND RENAL FUNCTION OF OCTREOSCAN
  • 批准号:
    7376276
  • 项目类别:
  • 资助金额:
    $0.85万
  • 财政年份:
    2005
  • 负责人:
    LOWELL B ANTHONY
  • 依托单位:
海外基金